| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |